Clayton Biotechnologies

Clayton Biotechnologies is a technology transfer and development company that serves as the commercialization arm for the Clayton Foundation for Research. Based in Houston, Texas, the company manages a diverse portfolio of life science intellectual property originating from the Foundation's global network of investigators at institutions such as the Salk Institute and the University of Texas. Clayton Biotechnologies focuses on advancing early-stage discoveries through the 'valley of death' by funding additional research and seeking strategic partnerships with pharmaceutical and biotechnology companies. Their therapeutic focus areas include oncology, diabetes, cardiovascular disease, and neuroscience. The company's business model centers on licensing technologies and fostering the creation of startup companies to bring novel medical innovations to market.